Nuclear Medicine and Molecular Imaging

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

Camparison of the Efficiency for Tc-99m Tin-colloid and Tc-99m Phytate in Sentinel Node Detection in Breast Cancer Patients

유방암 환자의 전초림프절 검사에서 Tc-99m Tin-colloid와 Tc-99m Phytate의 효용성에 대한 비교

  • Seok, Ju-Won (Department of Nuclear Medicine, College of Medicine, Chung-Ang University) ;
  • Kim, In-Ju (Department of Nuclear Medicine, College of Medicine, Pusan National University)
  • 석주원 (중앙대학교병원 핵의학과) ;
  • 김인주 (부산대학교병원 핵의학과)
  • Published : 2008.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Lymphoscintigraphy and sentinel node biopsy has become a standard method for detection of axillary lymph node metastasis in breast cancer patients, but the standard radiopharmaceutical was not prepared. About detection of axillary lymph node metastasis by lymphoscintigraphy and sentinel node biopsy in breast cancer patient, we compared the results of Tc-99m Tin-colloid and Tc-99m Phytate by subareolar injection. Materials and Methods: This study included 382 breast cancer patients who were performed operation during 2001-2008. Three hundred forty nine patients was injected 0.8ml of Tc-99m Tin-colloid (37-185 MBq) by subareolar injection. Thirty three patients was injected 0.8ml of Tc-99m Phytate (37-185 MBq). Lymphoscintigraphy was performed in supine position and sentinel node localization was performed by hand-held gamma probe in operation. Result: Among 349 patients by Tc-99m Tin-colloid, 312 cases (89.4%) localized the sentinel node by lymphoscintigraphy, 304 cases (87.1%) localized by gamma probe. Among 33 patients by Tc-99m Phytate, 32 cases (97.0%) localized by lymphoscintigraphy, 33 cases (100%) localized by gamma probe. Detection rate by lymphoscintigraphy and gamma probe was superior for Tc-99m Phytate compared to that with Tc-99m Tin-colloid, with a statistically significant difference. (p<0.05, p<0.05) Conclusion: Tc-99m Phytate is a better choice for localization of sentinel node than Tc-99m Tin-colloid in breast cancer patients.

목적 : 전초림프절 스캔과 전초림프철 생검은 유방암 환자에서 액와림프절 전이를 인지하기 위한 표준화된 방법으로 사용되게 되었지만, 표준화된 방사성의약품은 마련되어 있지 않다. 액와림프절 전이를 인지하기 위한 전초림프절 검사에 있어서 본 연구에서는 Tc-99m Tin-colloid와 Tc-99m Phytate의 결과를 비교하여 보았다. 대상 및 방법: 본 연구에서는 2001년에서 2008년까지 유방암으로 수술을 시행했던 381명의 환자를 대상으로 하였다. 349명의 환자는 Tc-99m Tin-colloid (37-185MBq) 0.8ml를 유륜하로 주사하였다. 33명의 환자는 Tc-99m Phytate (37-185 MBq) 0.8 ml를 유륜하로 주사하였다. 앉은 자세에서 림프신티그라피가 시행되었고, 수술 중에 감마프로브로 전초림프절을 발견하였다. 결과: Tc-99m Tin-celloid로 검사를 시행한 전체 349명의 환자 중에서 312명(89.4%)이 림프신티그라피에 의해 전초림프절이 발견되었고, 304명(87.1%)이 감마프로브에 의해 전초림프절이 발견되었다. 전날검사를 시행한 전체 33명의 환자 중에서 32명(97.0%)이 림프신티그라피에 의해 전초림프절이 발견되었고 33명(100%)이 감마프로브에 의해 전초림프절이 발견되었다. Tc-99m Phytate에 의한 림프신티그라피와 감마프로브에 의한 전초림프절 발견율은 Tc-99m Tin-celloid와 비교하여 통계학적으로 유의하게 높았다 (p<0.05, P<0.05). 결론: 유방암 환자에서 전초림프절을 발견하는데 있어 Tc-99m Phytate가 Tc-99m Tin-colloid보다 더 좋은 선택일 것이다.

Keywords

References

  1. Krag D, Weaver D, Ashikaga T, Moffat F, Llimberg VS, Shiever C, et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 1998;339:941-6 https://doi.org/10.1056/NEJM199810013391401
  2. Watanabe T, Kimijima I, Ohtake T, Tsuchiya A, Shishido F, Takenoshita S. Sentinel node biopsy with technetium-99m colloidal rhenium sulphide in patients with breast cancer. Br J Surg 2001;88:704-7 https://doi.org/10.1046/j.1365-2168.2001.01767.x
  3. Veronesi U, Paganelli G, Viale G, Luini A, Zurride S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-53 https://doi.org/10.1056/NEJMoa012782
  4. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1997;39:456-66 https://doi.org/10.1002/1097-0142(197702)39:2<456::AID-CNCR2820390214>3.0.CO;2-I
  5. Klag DN, Weaver DL, Alex JC. Surgical resection and radiolocalization of the sentinel node in breast cancer using gamma probe. Surg Oncol 1993;2:335-40 https://doi.org/10.1016/0960-7404(93)90064-6
  6. Bennett LR, Lago G, Cutaneous lymphoscintigraphy in malignant melanoma. Semin Nucl Med 1983;13:61-9 https://doi.org/10.1016/S0001-2998(83)80037-3
  7. Sadek S, Owunwanne A. Abdel Dayem HM, Yacoub T. Preparation and evaluation of Tc-99m hydorxyethyl starch as a potential radiopharmaceutical for lymphoscintigraphy: comparison with Tc-99m human serum albumin, Tc-99m dextran, and Tc-99m sulfur microcolloid. Lymphology 1989;22:157-66
  8. Kataoka M, Kawamura M, Hamada K, Itoh H, Nishiyama T, Hamamoto K. Quantitative lymphoscintigraphy using 99m-Tc human serum albumin in patients with previously treated uterine cancer. Br J Radiol 1991;64:1119-21 https://doi.org/10.1259/0007-1285-64-768-1119
  9. Tavares MGM, Sapienza MT, Galeb Jr NA, Belfort FA, Costa RR, Osorio CABT, et al. The use of Tc-99m phytate for sentinel node mapping in melanoma, breast cancer, and vulvar cancer: a study of 100 cases. Eur J Nucl Med 2001;28:1597-1604 https://doi.org/10.1007/s002590100625
  10. Strand SE, Persson BR. Quantitative lymphoscintigraphy I: Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J Nucl Med 1997;20:1038-46
  11. Alazraki NP, Eshima D, Eshima LA, Herda SC, Murray DR, Vansant JP, et al. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med 1997;27:55-67 https://doi.org/10.1016/S0001-2998(97)80036-0
  12. Pijper R, Meijer S, Hoekstra OS, Collet GJ, Comans EFL, Boom RPA, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997;38:366-8
  13. Subramanian G, McAfee JG, Mehta A, Blair RJ, Thomas ED. Tc-99m stannous phytate: a new in vivo colloid for imaging the reticuloendothelial system. J Nucl Med 1973;14:459
  14. Campbel J, Bellen JC, Baker RJ, Cook DJ. Technetium-99m calcium phytate - optimization of calcium content for liver and spleen scintigraphy: concise communication. J Nucl Med 1981;22: 157-60
  15. Alavi A, Staum MM, Shesol BF, Bloch PH. Technetium-99m Stannous phytate as an imaging agent for lymph node. J Nucl Med 1978;19:422-6
  16. Ege GN, Warbick A, Lymphoscintigraphy: a comparison of 99Tc(m) antimony sulphide colloid and 99mTc(m) stannous phytate. Br J Radiol 1979;52:124-9 https://doi.org/10.1259/0007-1285-52-614-124
  17. Wilher AJ, Mijinhout S, Franssen EJF. Radiopharmaceuticals in sentinel lymph-node detection. An overview. Eur J Nucl Med 1999;26 Suppl:36-42 https://doi.org/10.1007/PL00014793
  18. Eshima D, Fauconnier T, Eshima L, Thomback JR. Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. Semin Nucl Med 2000;30;25-32 https://doi.org/10.1016/S0001-2998(00)80059-8
  19. Kaplan WD, Davis MA, Rose CM. A comparison of two technetium-99m-labeled radiopharmaceuticals for lymphoscintigraphy: concise communication. J Nucl Med 1979;20:933-7